Mark Kaye, the chief financial officer, said the company took a "very disciplined approach between competitiveness and underwriting." ...
TD Cowen analyst Ryan Langston has maintained their bullish stance on ELV stock, giving a Buy rating on January 24.Invest with Confidence: ...
Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. "As part of our commitment to elevating whole health and advancing health beyond ...
Elevance executives talked about the cost trend environment for employer health plans Thursday, during a conference call with securities analysts. The Indianapolis-based health insurer and ...
Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...
Elevance Health (ELV – Research Report) received a Buy rating and a $485.00 price target from Cantor Fitzgerald analyst Sarah James yesterday.
It is time for patients to regain their voice in this debate and for physicians to use their knowledge and voices to advocate for them. We must protect Hoosier patients. Need a break? Play the USA ...
Health advocate Milele Kennedy is pushing back against Gov. Mike Braun's directive to stop advertising Medicaid programs, ...